Thomas R. Cox, Feb 2020
The Matrix Biology Society of Australia and New Zealand (MBSANZ) has just announced their “Paper of the Year” awards in the Early Career Research (ECR) and Mid Career Researcher (MCR) categories.
We are delighted that two papers from the Matrix & Metastasis lab and collaborators have been chosen for these awards
Thomas R. Cox, Dec 2019
I am delighted to share the news that our two wonderful Honours Students for 2019, Yordanos Setargew and Shivanjali Ratnaseelan have both been awarded First Class Honours from the School of Medical Sciences at UNSW Sydney. Yordanos for her project on “Targeting lysyl oxidase driven fibrosis in pancreatic ductal adenocarcinoma via copper inhibition” and Shivanjali for her project on the “Role of Extracellular Matrix Stiffness on Tumor Cell Response to Therapy”
Congratulations to both 🙂
Thomas R. Cox, Nov 2019
I’m delighted to announce that Elysse from the Matrix and Metastasis Team has just been awarded the St Vincent’s Clinic Foundation K&A Collins Cancer Research Award.
The St Vincent’s Clinic Foundation was established in 1992 to further the educational and research objectives of St Vincent’s Clinic and the surrounding precinct. The Foundation provides much-needed seed funding towards real research projects for real people including medical, basic and multidisciplinary research. The Awards are given to support bright young researchers who can put their research into real-world practise to improve patient care and health outcomes for the community.
The award which was announced at the annual Sandra David Oration, will give Elysse the opportunity (and $50,000 of seed funding) to further her novel work to find new and effective treatments for breast cancer to improve the clinical care and outcomes for patients.
Thomas R. Cox, Oct 2019
I am pleased to reveal that our recent paper in Nature Communications was just awarded the Paper of the Month award for September by the Matrix Biology Society of Australia and New Zealand (MBSANZ).
Thomas R. Cox, Jun 2019
Congratulations to Jess from the team, who today won the Australia and New Zealand Society for Cell and Developmental Biology (ANZCDB) Best Postdoctoral Poster Award.
The award was given as part of the NSW State Meeting of the ANZSCDB held at the University of Sydney. Jess’ poster presented her ongoing work developing new lysyl oxidase (LOX) inhibitors to treat pancreatic cancer.
The Australia and New Zealand Society for Cell and Developmental Biology exists to promote research and education in cell and developmental biology through the provision of a dynamic framework for collaboration and support. One of Australia’s oldest Scientific Societies, the ANZSCDB supports the cell and developmental biology research community across all levels, from students to senior researchers.
You can find our more about the ANZSCDB here.
Thomas R. Cox, Nov 2016
It is an absolute honour to announce that I was awarded the Journal of Biological Chemistry (JBC) Herbert Tabor Young Investigator Award at the 2016 Matrix Biology Society of Australia and New Zealand (MBSANZ) conference.
The JBC Herbert Tabor Young Investigator Awards are meant to honour Dr. Tabor’s invaluable contributions to the journal and to science as a whole. The awards recognise the innovators and achievers in new generations of researchers who exemplify his values of creativity and scientific excellence. Continue reading
Thomas R. Cox, Sep 2016
I’m honoured to have been awarded the British Society for Matrix Biology (BSMB) John Scott Young Investigator Award 2016 for contributions to matrix biology.
Thomas R. Cox, Aug 2013
Image courtesy of News-Medical.Net
The two winners of the AMSBio Poster Prize for the best posters at this years Beatson International Cancer Conference (7–10 July 2013) were Dr Thomas R. Cox and co-researchers for their work on ‘Deep proteomic analysis of the hypoxic secretome lysyl oxidase as a critical mediator of metastatic lesion formation in bone’, and Continue reading
Thomas R. Cox, Nov 2010
Today MedImmune announced the winners of its second annual European Cancer Research competition which highlights the research of the next generation of scientific leaders in cancer research.
Students and postdoctoral fellows from across Europe were invited to submit abstracts describing their research in the field of tumour microenvironments as part of the competition sponsored by MedImmune, AstraZeneca’s global biologics unit, which has a research facility in Cambridge, the United Kingdom.